Options Trading News

Traders are positioning for continued low volatility in Navidea Biopharmaceuticals.

More than 5,800 NAVB options have traded so far today, compared to a total daily average of 374 in the last month. The bulk of that volume came in a single call sale.

A trader sold a single block of 4,879 July 3 calls for $0.60, below the listed bid price at the time. Open interest in the strike was just 285 before today's trading began, so this is a new position.

The options weren't tied directly to any trading in the underlying shares identified by our systems today. But given that these contracts were struck at the money, it is very likely that the calls are sold against long shares.

NAVB is at $3 exactly this morning, unchanged on the day and continuing to trade in a tight range in place since the beginning of the year. Shares climbed from a low of $2.14 set in mid-November after hitting a high of $4.77 in July.

optionMONSTER® provides stock market insight, advanced options education, and actionable trade ideas to meet the needs of do-it-yourself investors. After spending decades in the trading pits of Chicago, Jon 'DRJ' and Pete Najarian founded the company in 2005 to help people better manage their own investment portfolios.